Danz, K.; Fleddermann, J.; Koch, M.; Fecioru, E.; Maahs, L.; Kinsinger, N.; Krämer, J.; Kraegeloh, A.; Wagner, S.
Evaluation of the Transport and Binding of Dopamine-Loaded PLGA Nanoparticles for the Treatment of Parkinson’s Disease Using In Vitro Model Systems. Pharmaceutics 2024, 16, 571.
https://doi.org/10.3390/pharmaceutics16050571
AMA Style
Danz K, Fleddermann J, Koch M, Fecioru E, Maahs L, Kinsinger N, Krämer J, Kraegeloh A, Wagner S.
Evaluation of the Transport and Binding of Dopamine-Loaded PLGA Nanoparticles for the Treatment of Parkinson’s Disease Using In Vitro Model Systems. Pharmaceutics. 2024; 16(5):571.
https://doi.org/10.3390/pharmaceutics16050571
Chicago/Turabian Style
Danz, Karin, Jana Fleddermann, Marcus Koch, Elena Fecioru, Lorenz Maahs, Nicole Kinsinger, Johannes Krämer, Annette Kraegeloh, and Sylvia Wagner.
2024. "Evaluation of the Transport and Binding of Dopamine-Loaded PLGA Nanoparticles for the Treatment of Parkinson’s Disease Using In Vitro Model Systems" Pharmaceutics 16, no. 5: 571.
https://doi.org/10.3390/pharmaceutics16050571
APA Style
Danz, K., Fleddermann, J., Koch, M., Fecioru, E., Maahs, L., Kinsinger, N., Krämer, J., Kraegeloh, A., & Wagner, S.
(2024). Evaluation of the Transport and Binding of Dopamine-Loaded PLGA Nanoparticles for the Treatment of Parkinson’s Disease Using In Vitro Model Systems. Pharmaceutics, 16(5), 571.
https://doi.org/10.3390/pharmaceutics16050571
